Folder View



Guidance on how to use bisphosphonates and other bone modifying drugs in haematology and oncology patients.Key words:Oncology, Haematology, Myeloma, Bone, Bisphosphonates, Denosumab
Valid To: 08/04/2023
Publication Type: Guidelines
General overview of CINV including guidance on the prescribing of antiemetic's for CINV
Valid To: 07/06/2022
Publication Type: Guidelines
How to assess and manage suspected Cancer Associated Thrombosis in patients receiving chemotherapy including what education should be provided to patients.
Valid To: 19/02/2023
Publication Type: Guidelines
How to assess and manage Systemic Anti-Cancer therapy induced Diarrhoea, patient education and management.
Valid To: 04/06/2022
Publication Type: Guidelines
Appropriate management of neutropenic sepsis in oncology patients
Valid To: 07/07/2020
Publication Type: Guidelines
To authorise appropriately qualified non-medical practitioners to request specified X-ray examinations, adhering to the ionising radiation Regulations IR(ME)R and the Royal College of radiologists guidelines
Valid To: 21/02/2022
Publication Type: Guidelines
This guideline applies to patients presenting to RCHT with potential side effects from immunotherapy treatment for cancer. It defines the optimal management.
Valid To: 25/11/2022
Publication Type: Guidelines
How to assess and manage patients with suspected malignant spinal cord compression
Valid To: 30/08/2022
Publication Type: Guidelines
This guideline applies to patients presenting to RCHT with potential bowel obstruction as a consequence of cancer. It defines the agreed optimal management.
Valid To: 25/11/2022
Publication Type: Guidelines
This guideline applies to patients presenting to RCHT with hypercalcaemia (high serum calcium) secondary to malignancy. It defines the optimal management.
Valid To: 30/08/2022
Publication Type: Guidelines
The outline for the management of the requirement for the 24 Hour Advice Line Telephone for patients receiving SACT.The procedure for management of the 24 Hour Advice Line Telephone for patients receiving SACT
Valid To: 26/02/2022
Publication Type: Policies
Policy for the use of the mobile cancer care unit in Cornwall
Valid To: 18/12/2022
Publication Type: Policies
This document outlines guidelines for the prevention and management of extravasation and the rapid treatment of SACT injuries. It provides a guideline to assist practitioners in the care of patients who may have experienced a SACT extravasation injury.
Valid To: 14/03/2022
Publication Type: Guidelines
Guidance and education on the prevention and management of oral complications in patients receiving SACT.
Valid To: 04/06/2022
Publication Type: Guidelines
Guidelines for the use and care of scalp cooling equipment
Valid To: 04/06/2022
Publication Type: Guidelines
Recommendations for the prescribing and administration of mesna with ifosfamide and cyclophosphamide for adult cancer patients.
Valid To: 14/11/2022
Publication Type: Guidelines
Defines the local guideline for safe administration of intrathecal chemotherapy, in accordance with national guidelines.
Valid To: 30/12/2022
Publication Type: Guidelines
Defines the policy for safe handling and administration of cytotoxic SACT for the treatment of cancer.
Valid To: 21/11/2022
Publication Type: Policies
Guidelines on when it is appropriate to use GSCF in haematology and oncology patients undergoing chemotherapy or stem cell harvest.
Valid To: 04/06/2022
Publication Type: Guidelines